Kura Oncology (KURA) Research & Development (2014 - 2026)
Kura Oncology (KURA) reported Research & Development of $61.89 million for Q2 2026, down 1.4% from $62.79 million a year earlier and down 5.2% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Research & Development (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kura Oncology's Research & Development came in at $245.91 million, up 15.6% year-over-year; for FY2025, it came in at $251.07 million, up 47.7% from FY2024.
- Research & Development has increased for eight consecutive years, with a five-year compound annual growth rate of 33.0% (FY2020 to FY2025).
- By year, Research & Development came in at $169.97 million in FY2024 (+47.5%), $115.24 million in FY2023 (+24.2%), $92.81 million in FY2022 (+9.6%) and $84.72 million in FY2021 (+40.3%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q1 2025.
- Year over year, Research & Development gained in five of the last six quarters, with growth averaging 38.4%.
- The high point for year-over-year Research & Development in five years was Q4 2024 (growth of 60.7%); the low point was Q2 2026 (a decline of 1.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Kura Oncology | 952.70 Mn | 952.70 Mn | 20.63 Mn | 61.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.89 Mn |
| Mar 31, 2026 | 65.26 Mn |
| Jun 30, 2025 | 62.79 Mn |
| Mar 31, 2025 | 55.97 Mn |
| Dec 31, 2024 | 52.27 Mn |
| Sep 30, 2024 | 41.71 Mn |
| Jun 30, 2024 | 39.73 Mn |
| Mar 31, 2024 | 36.27 Mn |
| Dec 31, 2023 | 32.53 Mn |
| Sep 30, 2023 | 29.33 Mn |
| Jun 30, 2023 | 28.18 Mn |
| Mar 31, 2023 | 25.19 Mn |
| Dec 31, 2022 | 22.67 Mn |
| Sep 30, 2022 | 24.97 Mn |
| Jun 30, 2022 | 24.26 Mn |
| Mar 31, 2022 | 20.91 Mn |
| Dec 31, 2021 | 20.96 Mn |
| Sep 30, 2021 | 22.37 Mn |
| Jun 30, 2021 | 21.07 Mn |
| Mar 31, 2021 | 20.32 Mn |
API Access
Kura Oncology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();